Effects of theophylline on lymphocyte phosphodiesterase activity. 1998

Y Tohda, and H Nakahara, and H Kubo, and K Ohkawa, and M Fukuoka, and S Nakajima
Fourth Department of Internal Medicine, Kinki University School of Medicine, Osakasayama, Osaka, Japan.

1. To clarify part of the bronchodilating effects of theophylline, lymphocyte cyclic AMP (cAMP) and phosphodiesterase (PDE) activity in asthmatic patients and healthy adults were measured. 2. No clear differences in lymphocyte PDE activity were found regarding sexes, ages or the types of asthma. 3. Lymphocyte PDE activity in the asthma group was significantly higher than that in the control group. 4. Lymphocyte cAMP significantly increased at 30 and 60 min after intravenous injection of aminophylline in the asthma group. 5. Lymphocyte PDE activity significantly decreased 60 min after intravenous injection of aminophylline in the asthma group.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010726 Phosphodiesterase Inhibitors Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. Phosphodiesterase Antagonists,Phosphodiesterase Inhibitor,Phosphoric Diester Hydrolase Inhibitors,Antiphosphodiesterases,Inhibitor, Phosphodiesterase
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D005260 Female Females
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic

Related Publications

Y Tohda, and H Nakahara, and H Kubo, and K Ohkawa, and M Fukuoka, and S Nakajima
May 1974, Proceedings of the National Academy of Sciences of the United States of America,
Y Tohda, and H Nakahara, and H Kubo, and K Ohkawa, and M Fukuoka, and S Nakajima
March 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
Y Tohda, and H Nakahara, and H Kubo, and K Ohkawa, and M Fukuoka, and S Nakajima
January 1986, Farmakologiia i toksikologiia,
Y Tohda, and H Nakahara, and H Kubo, and K Ohkawa, and M Fukuoka, and S Nakajima
March 1995, The European respiratory journal,
Y Tohda, and H Nakahara, and H Kubo, and K Ohkawa, and M Fukuoka, and S Nakajima
January 1980, European journal of respiratory diseases. Supplement,
Y Tohda, and H Nakahara, and H Kubo, and K Ohkawa, and M Fukuoka, and S Nakajima
January 1978, Clinical and experimental pharmacology & physiology,
Y Tohda, and H Nakahara, and H Kubo, and K Ohkawa, and M Fukuoka, and S Nakajima
January 1988, Life sciences,
Y Tohda, and H Nakahara, and H Kubo, and K Ohkawa, and M Fukuoka, and S Nakajima
July 1971, Archives internationales de pharmacodynamie et de therapie,
Y Tohda, and H Nakahara, and H Kubo, and K Ohkawa, and M Fukuoka, and S Nakajima
December 1979, Biochemical Society transactions,
Y Tohda, and H Nakahara, and H Kubo, and K Ohkawa, and M Fukuoka, and S Nakajima
January 1980, Archivum immunologiae et therapiae experimentalis,
Copied contents to your clipboard!